Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Review

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

       
Total article views   HTML views PDF downloads Totals
19,616 Dovepress* 15,290+ 2,547 17,837
PubMed Central* 4,326 835 5,161
Totals 19,616 3,382 22,998
*Since 10 November 2010
+Since July 2016

View citations on PubMed Central and Google Scholar